Cardiovascular disease
Heart disease or cardiovascular diseases is the class of diseases that involve the heart or blood vessels (arteries and veins).[1] While the term technically refers to any disease that affects the cardiovascular system (as used in MeSH C14), it is usually used to refer to those related to atherosclerosis (arterial disease). These conditions have similar causes, mechanisms, and treatments.
In practice, cardiovascular disease is treated by cardiologists, thoracic surgeons, vascular surgeons, neurologists, and interventional radiologists, depending on the organ system that is being treated. There is considerable overlap in the specialties, and it is common for certain procedures to be performed by different types of specialists in the same hospital.
Most countries face high and increasing rates of cardiovascular disease. Each year, heart disease kills more Americans than cancer. In recent years, cardiovascular risk in women has been increasing and has killed more women than breast cancer.[2] A large histological study (PDAY) showed vascular injury accumulates from adolescence, making primary prevention efforts necessary from childhood.[3][4]
By the time that heart problems are detected, the underlying cause (atherosclerosis) is usually quite advanced, having progressed for decades. There is therefore increased emphasis on preventing atherosclerosis by modifying risk factors, such as healthy eating, exercise and avoidance of smoking.
Pathophysiology
Population based studies in the youth show that the precursors of heart disease start in adolescence. The process of atherosclerosis evolves over decades, and begins as early as childhood. The Pathobiological Determinants of Atherosclerosis in Youth Study demonstrated that intimal lesions appear in all the aortas and more than half of the right coronary arteries of youths aged 7–9 years. However, most adolescents are more concerned about other risks such as HIV, accidents, and cancer than cardiovascular disease.[5]
This is extremely important considering that 1 in 3 people will die from complications attributable to atherosclerosis. In order to stem the tide of cardiovascular disease, primary prevention is needed. Primary prevention starts with education and awareness that cardiovascular disease poses the greatest threat and measures to prevent or reverse this disease must be taken.
Diagnosis
Associated diagnostic markers
Screening
Some biomarkers are thought to offer a more detailed risk of cardiovascular disease. However, the clinical value of these biomarkers is questionable.[6] Currently, biomarkers which may reflect a higher risk of cardiovascular disease include:
- Higher fibrinogen and PAI-1 blood concentrations
- Elevated homocysteine, or even upper half of normal
- Elevated blood levels of asymmetric dimethylarginine
- High inflammation as measured by C-reactive protein
- Elevated blood levels of brain natriuretic peptide (also known as B-type) (BNP) [7]
Prevention
Evidence shows that the Mediterranean diet improves cardiovascular outcomes.[8]
Management
Unlike many other chronic. medical conditions, Cardiovascular disease is treatable and reversible, even after a long history of disease. Treatment is primarily focused on diet and stress reduction [9] [10] [11] however frequently includes medication.
Epidemiology
Disability-adjusted life year for cardiovascular diseases per 100,000 inhabitants in 2004.
[12]
no data less than 900 900-1650 1650-2300 2300-3000 3000-3700 3700-4400 4400-5100 5100-5800 5800-6500 6500-7200 7200-7900 Over 7900
Research
The first studies on cardiovascular health were performed in 1949 by Jerry Morris using occupational health data and were published in 1958.[13] The causes, prevention, and/or treatment of all forms of cardiovascular disease remain active fields of biomedical research, with hundreds of scientific studies being published on a weekly basis. A trend has emerged, particularly in the early 2000s, in which numerous studies have revealed a link between fast food and an increase in heart disease. These studies include those conducted by the Ryan Mackey Memorial Research Institute, Harvard University and the Sydney Center for Cardiovascular Health. Many major fast food chains, particularly McDonald's, have protested the methods used in these studies and have responded with healthier menu options.
A fairly recent emphasis is on the link between low-grade inflammation that hallmarks atherosclerosis and its possible interventions. C-reactive protein (CRP) is an inflammatory marker that may be present in increased levels in the blood in patients at risk for cardiovascular disease. Its exact role in predicting disease is the subject of debate.
Some areas currently being researched include possible links between infection with Chlamydophila pneumoniae and coronary artery disease. The Chlamydia link has become less plausible with the absence of improvement after antibiotic use.[14]
See also
- Alcohol and cardiovascular disease
- British Heart Foundation
- Heart failure
- HeartScore
References
- ↑ Maton, Anthea (1993). Human Biology and Health. Englewood Cliffs, New Jersey: Prentice Hall. ISBN 0-13-981176-1.
- ↑ United States (1999). "Chronic Disease Overview". United States Government.
- ↑ Rainwater DL, McMahan CA, Malcom GT, et al. (Mar 1999). "Lipid and apolipoprotein predictors of atherosclerosis in youth: apolipoprotein concentrations do not materially improve prediction of arterial lesions in PDAY subjects. The PDAY Research Group". Arterioscler Thromb Vasc Biol. 19 (3): 753–61. PMID 10073983. http://atvb.ahajournals.org/cgi/pmidlookup?view=long&pmid=10073983.
- ↑ McGill HC, McMahan CA, Zieske AW, et al. (Aug 2000). "Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group". Arterioscler Thromb Vasc Biol. 20 (8): 1998–2004. PMID 10938023. http://atvb.ahajournals.org/cgi/pmidlookup?view=long&pmid=10938023.
- ↑ Vanhecke TE, Miller WM, Franklin BA, Weber JE, McCullough PA (Oct 2006). "Awareness, knowledge, and perception of heart disease among adolescents". Eur J Cardiovasc Prev Rehabil. 13 (5): 718–23. doi:10.1097/01.hjr.0000214611.91490.5e. PMID 17001210.
- ↑ Wang TJ, Gona P, Larson MG, Tofler GH, Levy D, Newton-Cheh C, Jacques PF, Rifai N, Selhub J, Robins SJ, Benjamin EJ, D'Agostino RB, Vasan RS (2006). "Multiple biomarkers for the prediction of first major cardiovascular events and death". N. Engl. J. Med. 355 (25): 2631–billy bob joe9. doi:10.1056/NEJMoa055373. PMID 17182988.
- ↑ Wang TJ, Larson MG, Levy D, et al. (Feb 2004). "Plasma natriuretic peptide alksdjalkdj levels and the risk of cardiovascular events and death". N Engl J Med. 350 (7): 655–63. doi:10.1056/NEJMoa031994. PMID 14960742. <!kjk-- Pls confirm this ref-->
- ↑ Walker C, Reamy BV (April 2009). "Diets for cardiovascular disease prevention: what is the evidence?". Am Fam Physician 79 (7): 571–8. PMID 19378874.
- ↑ Ornish, Dean, "et al." (Jul 1990). "'Can lifestyle changes reverse coronary heart disease?' The Lifestyle Heart Trial.". Lancet 336 (8708): 129–33. doi:10.1016/0140-6736(90)91656-U. PMID 1973470.
- ↑ Ornish, D., Scherwitz, L. W., Doody, R. S., Kesten, D., McLanahan, S. M., Brown, S. E. "et al." (1983). "Effects of stress management training and dietary changes in treating ischemic heart disease". JAMA 249 (54): 54. doi:10.1001/jama.249.1.54.
- ↑ Ornish, D., Scherwitz, L. W., Billings, J. H., Brown, S. E., Gould, K. L., Merritt, T. A. "et al." (1998). "Intensive lifestyle changes for reversal of coronary heart disease". JAMA 280 (280): 2001. doi:10.1001/jama.280.23.2001. PMID 9863851.
- ↑ "WHO Disease and injury country estimates". World Health Organization. 2009. http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/index.html. Retrieved Nov. 11, 2009.
- ↑ Coronary Heart Disease and Physical Activity of Work by J. N. Morris and Margaret D. Crawford, British Medical Journal 1958 ; 2(5111): 1485–1496 [1]
- ↑ Andraws R, Berger JS, Brown DL (Jun 2005). "Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials". JAMA 293 (21): 2641–7. doi:10.1001/jama.293.21.2641. PMID 15928286.
External links
Informational
Public information
Pathology: Medical conditions and ICD code |
|
(Disease / Disorder / Illness, Syndrome / Sequence, Symptom / Sign, Injury, etc.) |
|
(A/B, 001-139) |
|
|
(C/D,
140-239 &
279-289) |
|
|
|
Myeloid hematologic (D50-D77, 280-289)
|
|
|
|
|
|
|
(E, 240-278) |
|
|
(F, 290-319) |
|
|
(G, 320-359) |
Nervous system disease (CNS, PNS) · Neuromuscular disease
|
|
(H, 360-389) |
Eye disease · Ear disease
|
|
(I, 390-459) |
|
|
(J, 460-519) |
Respiratory disease (Obstructive lung disease, Restrictive lung disease, Pneumonia)
|
|
(K, 520-579) |
Stomatognathic disease (Tooth disease) · Digestive disease (Esophageal, Stomach, Enteropathy, Liver, Pancreatic)
|
|
(L, 680-709) |
Skin disease · skin appendages (Nail disease, Hair disease, Sweat gland disease)
|
|
(M, 710-739) |
Musculoskeletal disorders: Myopathy · Arthropathy · Osteochondropathy (Osteopathy, Chondropathy)
|
|
(N, 580-629) |
Urologic disease (Nephropathy, Urinary bladder disease) · Male genital disease · Breast disease · Female genital disease
|
|
(O, 630-679) |
Complications of pregnancy · Obstetric labor complication · Puerperal disorder
|
|
(P, 760-779) |
Fetal disease
|
|
(Q, 740-759) |
|
|
(R, 780-799) |
|
|
(S/T, 800-999) |
|
|
Cardiovascular disease: heart disease · Circulatory system pathology (I00-I52, 390-429) |
|
Ischaemic |
|
CAD · Coronary thrombosis · Coronary vasospasm · Coronary artery aneurysm · Coronary artery dissection · Myocardial Bridge
|
|
|
|
|
Sequelae
|
hours (Myocardial stunning, Hibernating myocardium) · days (Myocardial rupture) · weeks (Aneurysm of heart/Ventricular aneurysm, Dressler's syndrome)
|
|
|
Layers |
Pericardium
|
Pericarditis (Acute, Chronic/Constrictive) · Pericardial effusion (Hemopericardium, Cardiac tamponade)
|
|
|
Myocarditis (Chagas disease)
Cardiomyopathy: Dilated (Alcoholic) · Hypertrophic · Restrictive (Loeffler endocarditis, Cardiac amyloidosis, Endocardial fibroelastosis)
Arrhythmogenic right ventricular dysplasia
|
|
Endocardium/
valves
|
|
Infective endocarditis (Subacute bacterial endocarditis) · noninfective endocarditis (Nonbacterial thrombotic endocarditis, Libman-Sacks endocarditis)
|
|
Valves
|
mitral (regurgitation, prolapse, stenosis) · aortic (stenosis, insufficiency) · tricuspid (stenosis, insufficiency) · pulmonary (stenosis, insufficiency)
|
|
|
|
Conduction/
arrhythmia |
|
Sinus bradycardia · Sick sinus syndrome
Heart block: Sinoatrial · AV (1°, 2°, 3°) · Intraventricular (Bundle branch/Right/Left, Left anterior fascicular/Left posterior fascicular, Bifascicular/Trifascicular) · Adams-Stokes syndrome
|
|
|
Supraventricular
|
Atrial (Multifocal) · Junctional (AV nodal reentrant, Junctional ectopic)
|
|
Ventricular
|
Torsades de pointes · Catecholaminergic polymorphic · Accelerated idioventricular rhythm
|
|
|
Premature contraction
|
Atrial · Ventricular
|
|
Pre-excitation syndrome
|
Wolff-Parkinson-White · Lown-Ganong-Levine
|
|
Flutter/fibrillation
|
|
|
|
Wandering pacemaker · Ectopic pacemaker/Ectopic beat · Parasystole · Multifocal atrial tachycardia · Pacemaker syndrome
|
|
|
Romano-Ward syndrome · Andersen-Tawil syndrome · Jervell and Lange-Nielsen syndrome
|
|
|
Sudden cardiac death · Asystole · Pulseless electrical activity · Sinoatrial arrest
|
|
Other/ungrouped
|
hexaxial reference system (Right axis deviation, Left axis deviation) · QT (Short QT syndrome) · T (T wave alternans) · ST (Osborn wave, ST elevation, ST depression)
|
|
|
Cardiomegaly |
Ventricular hypertrophy (Left, Right/Cor pulmonale) · Atrial enlargement (Left, Right)
|
|
Other |
|
|
|
|
|
proc, drug (C1A/1B/1C/), blte
|
|
|
|
Cardiovascular disease: vascular disease · Circulatory system pathology (I70–I99, 440–456) |
|
Arteries, arterioles
and capillaries |
|
Arteritis (Aortitis) · Buerger's disease
|
|
Arterial occlusive disease/
peripheral vascular disease
|
Arteriosclerosis
|
Atherosclerosis (Foam cell, Fatty streak, Atheroma, Intermittent claudication) · Monckeberg's arteriosclerosis · Arteriolosclerosis (Hyaline, Hyperplastic, oxycholesterol, cholesterol, LDL, trans fat)
|
|
Stenosis
|
Renal artery stenosis · Carotid artery stenosis
|
|
Other
|
|
|
|
|
torso: Aortic aneurysm (Thoracic aortic aneurysm, Abdominal aortic aneurysm) · Aortic dissection · Coronary artery aneurysm
head/neck: Cerebral aneurysm · Intracranial berry aneurysm · Carotid artery dissection · Vertebral artery dissection · Familial aortic dissection
|
|
Vascular malformation
|
Arteriovenous malformation · Arteriovenous fistula · Telangiectasia (Hereditary hemorrhagic telangiectasia)
|
|
|
Spider angioma · Halo nevus · Cherry hemangioma
|
|
|
Veins |
|
Phlebitis
|
|
Venous thrombosis/
Thrombophlebitis
|
primarily lower limb (Deep vein thrombosis)
abdomen (May-Thurner syndrome, Portal vein thrombosis, Budd–Chiari syndrome, Renal vein thrombosis)
upper limb/torso (Paget-Schroetter disease, Mondor's disease)
head (Cerebral venous sinus thrombosis)
Post-thrombotic syndrome
|
|
|
Varicocele · Gastric varices · Portacaval anastomosis ( Hemorrhoid, Esophageal varices, Caput medusae)
|
|
Other
|
Superior vena cava syndrome · Inferior vena cava syndrome · Venous ulcer · Chronic venous insufficiency · Chronic cerebrospinal venous insufficiency
|
|
|
Arteries or veins |
|
|
Blood pressure |
|
Hypertensive heart disease · Hypertensive nephropathy · Essential hypertension · Secondary hypertension (Renovascular hypertension) · Pulmonary hypertension · Malignant hypertension · Benign hypertension · Systolic hypertension · White coat hypertension
|
|
|
|
|
|
|
anat(a:h,u,t,a,l,v:h,u,t,a,l)/phys/devp/cell/
|
|
proc, drug(C2s/,C3,C4,C5,,C8,C9)
|
|
|
|
Certain conditions originating in the perinatal period / fetal disease (P, 760-779) |
|
Maternal factors and
complications of pregnancy,
labour and delivery |
placenta: Placenta praevia · Placental insufficiency · Twin-to-twin transfusion syndrome
chorion/amnion: Chorioamnionitis
umbilical cord: Umbilical cord prolapse · Nuchal cord · Single umbilical artery
|
|
Length of gestation
and fetal growth |
Small for gestational age/Large for gestational age · Preterm birth/Postmature birth · Intrauterine growth restriction
|
|
Birth trauma |
scalp (Cephalhematoma, Chignon, Caput succedaneum, Subgaleal hemorrhage) · Brachial plexus lesion (Erb's palsy, Klumpke paralysis)
|
|
By system |
Respiratory
|
Intrauterine hypoxia · Infant respiratory distress syndrome · Transient tachypnea of the newborn · Meconium aspiration syndrome · pleural disease ( Pneumothorax, Pneumomediastinum) · Wilson-Mikity syndrome · Bronchopulmonary dysplasia
|
|
Cardiovascular
|
Pneumopericardium · Persistent fetal circulation
|
|
|
Vitamin K deficiency (Haemorrhagic disease of the newborn)
HDN (ABO • Anti-Kell • Rh c • Rh D • Rh E) · Hydrops fetalis · Hyperbilirubinemia (Kernicterus, Neonatal jaundice)
Velamentous cord insertion
Intraventricular hemorrhage (Germinal matrix hemorrhage)
Anemia of prematurity
|
|
Digestive
|
Ileus · Necrotizing enterocolitis · Meconium peritonitis
|
|
|
Erythema toxicum · Sclerema neonatorum
|
|
Nervous system
|
Periventricular leukomalacia
|
|
Musculoskeletal
|
Gray baby syndrome · muscle tone (Congenital hypertonia, Congenital hypotonia)
|
|
|
Infectious |
Perinatal infection (Congenital rubella syndrome, Neonatal herpes simplex) · Omphalitis · Neonatal sepsis (Group B streptococcal infection) · Neonatal conjunctivitis
|
|
Other |
Perinatal mortality (Stillbirth, Infant mortality) · Neonatal withdrawal
|
|
|
|